Company profile
Esperion Therapeutics, Inc. Insider Trading
ESPREvery SEC Form 4 insider trading filing for Esperion Therapeutics, Inc. (ESPR) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001434868
- Filings
- 105
- Insiders
- 16
- Last filing
- 2026-07-13
Activity summary
No insider transactions in the last 30 days. The most recent was on July 13, 2026, when Sheldon L. Koenig reported 2,121,094 shares (Disposition). 105 filings from 16 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Esperion Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $240K.
90 day insight
Over the last 90 days, Esperion Therapeutics, Inc. insiders filed 30 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Sheldon L. Koenig with 4 transactions totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Sheldon L. Koenig | ESPR | Disposition | 2,121,094 | — | — |
| Jul 13, 2026 | Sheldon L. Koenig | ESPR | Disposition | 642,000 | — | — |
| Jul 13, 2026 | Sheldon L. Koenig | ESPR | Disposition | 753,000 | — | — |
| Jul 13, 2026 | Sheldon L. Koenig | ESPR | Disposition | 647,460 | — | — |
| Jul 13, 2026 | John Craig Thompson | ESPR | Disposition | 79,873 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ESPR" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Esperion Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →